Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

MEC Plus

Speciality

Author / Speaker

Title

Type of Media

Events

Search Everything

«
1
…
84
85
86
87
88
…
96
»

Case Presentation - Lung - Immunotherapy Toxicity Case, How to Manage and Whether toPermanently Stop or Not

Case Presentation - Lung - Immunotherapy Toxicity Case, How to Manage and Whether toPermanently Stop or Not

Helen Shih

Immunotherapy selection in mRCC

Immunotherapy selection in mRCC

Sandy Srinivas. MD

Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care

Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care

J. Marie Suga, MD

Triple-negative and Hereditary Breast Cancer

Triple-negative and Hereditary Breast Cancer

Melinda Telli, M.D.

Managing Toxicities from TKI EGFR and ALK Inhibitors

Managing Toxicities from TKI EGFR and ALK Inhibitors

Jane Arboleda, APRN

Managing Toxicities from B-RAF and MEKInhibitors

Managing Toxicities from B-RAF and MEKInhibitors

Alba Baglietto, RN, BSN

B-Cell Lymphomas including Hodgkin’s Disease

B-Cell Lymphomas including Hodgkin’s Disease

William Caceres-Perkins, MD, FACP

CDK4-6 and PIK3CA Inhibitors in Breast Cancer Management

CDK4-6 and PIK3CA Inhibitors in Breast Cancer Management

Richard S. Finn, MD

The Role of Immunotherapy in Breast Cancer

The Role of Immunotherapy in Breast Cancer

Richard S. Finn, MD

Current Status of Biosimilars and Recent Approvals

Current Status of Biosimilars and Recent Approvals

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Immunologic Therapy for Melanoma

Immunologic Therapy for Melanoma

Geoffrey T. Gibney, MD

Frontline Therapy in Myeloma - How to Decide the Best Approach

Frontline Therapy in Myeloma - How to Decide the Best Approach

Sergio Giralt, MD

Immunotherapy in Gastrointestinal Tumors (CRC, Esophageal, and other)

Immunotherapy in Gastrointestinal Tumors (CRC, Esophageal, and other)

Axel Grothey, MD

Predictive and Prognostic BiomarkersUsing Genomic Profile in Adjuvant Breast Cancer

D. Constanza Guaqueta, MD

Handling the Most Common Toxicities fromIO - Endocrinopathies, Pneumonitis, SkinRash-Pruritus, and Adrenal Insufficiency

Handling the Most Common Toxicities fromIO - Endocrinopathies, Pneumonitis, SkinRash-Pruritus, and Adrenal Insufficiency

Jeanelle King, PA-C

Kidney and Bladder Cancers as Targets for Immunotherapy

Kidney and Bladder Cancers as Targets for Immunotherapy

Alan J. Koletsky, MD

Managing Expectations-Goals of Care & Family Support

Managing Expectations-Goals of Care & Family Support

Mayra A. Lima, ARNP, MSN, FNP-C

Immunotherapy in Head and Neck Cancer

Immunotherapy in Head and Neck Cancer

Raja Mudad, MD, FACP

Chronic Lymphocytic Leukemia - Frontline & Relapsed Disease

Chronic Lymphocytic Leukemia - Frontline & Relapsed Disease

Javier Pinilla-Ibarz, MD, PhD

NTRK, Exon 20 insertions, and Potential Novel Pathways in Lung Cancer

NTRK, Exon 20 insertions, and Potential Novel Pathways in Lung Cancer

Luis E. Raez, MD

HER-2 Disease - Neo-, Adjuvant,Metastatic Setting

HER-2 Disease - Neo-, Adjuvant,Metastatic Setting

Noridza Rivera-Rodriguez, MD

Pancreas and Hepatobiliary Tract

Pancreas and Hepatobiliary Tract

Caio Max S. Rocha Lima, MD

RET, MET, and BRAF Mutant Lung Cancer Tumors

RET, MET, and BRAF Mutant Lung Cancer Tumors

Edgardo S. Santos, MD, FACP

Lung Cancer Immunotherapy

Lung Cancer Immunotherapy

Pedro G. Solivan, MD

Novel Approaches for Early Stages-Locally Advanced Esophageal and GE Junction Tumors

Novel Approaches for Early Stages-Locally Advanced Esophageal and GE Junction Tumors

Pedro G. Solivan, MD

SCLC & Squamous NSCLC - New Standards

SCLC & Squamous NSCLC - New Standards

Janakiraman Subramanian, MD, MPH

CAR-T Cells and BMT Learning How to Deal with Complications

CAR-T Cells and BMT Learning How to Deal with Complications

Adalberto Torres-Hernandez, MSN, BA, CERN, CWCMS

Colorectal Cancer - Novel Insights andTherapies (except IO)

Colorectal Cancer - Novel Insights andTherapies (except IO)

Luis Baez Vallecillo, MD

Adrienne, Cancer Survivorship Program

Adrienne, Cancer Survivorship Program

Adrienne Vazquez-Guerra, MSN, ACNP-BC, AOCNP

EGFR & ALK Inhibitors for Mutated Lung Cancer Tumors

EGFR & ALK Inhibitors for Mutated Lung Cancer Tumors

Miguel A. Villalona-Calero, MD, FACP, FAAAS

Displaying 2,551 - 2,580 of 2,875

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Useful Links

Library
Live Events

Categories

MEC Basic
MEC Plus
Purchased

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok